tiprankstipranks
Trending News
More News >
Promising Clinical Data and Safety Profile of Nurix Therapeutics’ Bexobrutideg Drives Buy Rating
PremiumRatingsPromising Clinical Data and Safety Profile of Nurix Therapeutics’ Bexobrutideg Drives Buy Rating
24d ago
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
Premium
The Fly
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
1M ago
Innovative Capabilities and Promising Data Drive Buy Rating for Nurix Therapeutics
Premium
Ratings
Innovative Capabilities and Promising Data Drive Buy Rating for Nurix Therapeutics
1M ago
Nurix Therapeutics price target lowered to $30 from $35 at UBS
PremiumThe FlyNurix Therapeutics price target lowered to $30 from $35 at UBS
2M ago
Hold Rating for Nurix Therapeutics Amid Competitive Challenges and Strategic Uncertainties
Premium
Ratings
Hold Rating for Nurix Therapeutics Amid Competitive Challenges and Strategic Uncertainties
2M ago
Nurix Therapeutics price target lowered to $32 from $35 at Oppenheimer
Premium
The Fly
Nurix Therapeutics price target lowered to $32 from $35 at Oppenheimer
2M ago
Nurix Therapeutics, Inc. Earnings Report: Is it a Beat?
PremiumEarning ReleasesNurix Therapeutics, Inc. Earnings Report: Is it a Beat?
2M ago
Nurix Therapeutics Q1 2025 Financial Highlights
Premium
Company Announcements
Nurix Therapeutics Q1 2025 Financial Highlights
2M ago
Nurix Therapeutics reports Q1 EPS (67c), consensus (76c)
Premium
The Fly
Nurix Therapeutics reports Q1 EPS (67c), consensus (76c)
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100